Matthew Downham, CEPI’s director of manufacturing and supply chain networks, tells GEN, “Through this partnership, CEPI and Samsung Biologics will establish a pre-agreed, ready-to-activate ...

In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.

The new childhood immunization policies and vaccine schedule from the U.S. Department of Health and Human Services is the ...

Signed Memorandum of Understanding supports "Plan Mexico," Mexico's strategic initiative to build a local mRNA ...

Good afternoon, and welcome to the Health Brief newsletter. Washington was promised inches of snow in what turned out to be a bust. Overreacting about the weather? Oh, D.C. is so back.

In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.

Also in this roundup: a group salutes a Virginia Athletics communicator’s career, Yale lauds a president emeritus, and more.

Updated 2024-2025 COVID-19 vaccines significantly reduced the risk for hospitalization and severe outcomes despite the emergence of new viral lineages.

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...

JP Nadda launched indigenously made Td vaccine in Kasauli, adding it to UIP. India to supply 55 lakh doses, expand production ...

India, Feb. 22 -- Union Health Minister JP Nadda on Saturday launched the indigenously manufactured tetanus and adult ...